Akero ' s Fatty Liver Disease Drug Lessens Scarring in Mid-stage Trial Akero ' s Fatty Liver Disease Drug Lessens Scarring in Mid-stage Trial
Akero Therapeutics ' experimental drug for a type of fatty liver disease significantly reduced scarring after nearly two years in a mid-stage study, it said on Monday, as the...Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Gastroenterology Source Type: news
More News: Fatty Liver Disease (FLD) | Gastroenterology | Liver | Liver Disease | Pathology | Study | Urology & Nephrology